• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Diasend Integrates with Abbott’s FreeStyle Libre to Simplify Diabetes Data Management

by HITC Staff 06/10/2016 1 Comment

Abbott's FreeStyle Libre system

In collaboration with the diabetes care business of Abbott, the global healthcare company, Diasend now introduces seamless integration using the mobile app LibreLink*, designed for the FreeStyle® Libre flash glucose monitoring system. 

Starting now, it is possible for patients using Abbott’s FreeStyle Libre system in countries where the LibreLink app is available to import information directly into diasend® – the industry leading solution for diabetes data management. All that is needed is a compatible Android smartphone** equipped with the LibreLink app, a connected FreeStyle Libre sensor and the one-time effort of connecting the two systems.

The current glucose level is read by simply scanning the sensor with the back of the Android phone. Data is then automatically populated into the patient’s diasend® account through the cloud, which can be easily linked with one’s health care provider – meaning that information is passively mirrored into the linked clinic account.

“At Abbott, we are committed to helping people achieve their best health so we strive to give our customers access to the best possible products and services to help them better manage their diabetes,” says Eric Davis, director of New Product Innovation, diabetes care, Abbott. “Our collaboration with Diasend is one more step in that direction and we are excited to bring our customers even closer together with their physicians.”

With diasend®, patients will also be able to view their FreeStyle Libre data combined with information from any other diasend® compatible device, such as insulin pumps, blood glucose meters and/or activity trackers. With everything securely stored and easily accessible in one place for both patients and health care providers.

The diasend® system enables users to easily upload, analyze and store data from more than 140 different glucose meters, insulin pumps, CGM systems (continuous glucose monitoring) and leading activity trackers. All completely free for patients. The company’s constantly evolving solution supports cloud-to-cloud integration as well as mobile uploads via wireless technologies such as BLE and NFC. 

All combined, this makes diasend® the most universal data aggregation solution in the world – and with more than 400,000 unique active patients during the last 12 months the system now boasts over 1 million unique device uploads. 

Tagged With: Diasend, FreeStyle® Libre, LibreLink

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Popular

Survey: Clinician Burnout Is A Public Health Crisis Demanding Urgent Action

17 Execs Share How Health IT Can Address Clinician Burnout, Staffing, & Capacity

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Northwell Health Extends Contract with Allscripts Sunrise Platform Through 2027

Northwell to Deploy Epic Enterprise EHR Platform Across System

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Pfizer Acquires Seagen for $43B to Tackle Cancer

Pfizer Acquires Seagen for $43B to Tackle Cancer

5 Key Trends Driving Purchasing Decisions in Healthcare IT

5 Key Trends Driving Purchasing Decisions in Healthcare IT

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Dr. Arti Masturzo

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |